Stockreport

XORTX Announces New Clinical Advisory Board Member [Yahoo! Finance]

XORTX Therapeutics Inc.  (XRTX) 
PDF WKN: A3UNZ) , a biopharmaceutical company focused on developing innovative therapies to treat autosomal dominant polycystic kidney disease (“ADPKD”), is pleased to annou [Read more]